143 related articles for article (PubMed ID: 4036990)
1. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
Meyer K; Williams EC
Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
[TBL] [Abstract][Full Text] [Related]
2. Pathologic hyperfibrinolysis associated with amyloidosis: clinical response to epsilon amino caproic acid.
Chang JC; Kane KK
Am J Clin Pathol; 1984 Mar; 81(3):382-7. PubMed ID: 6702732
[TBL] [Abstract][Full Text] [Related]
3. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
Schwartz BS; Williams EC; Conlan MG; Mosher DF
Ann Intern Med; 1986 Dec; 105(6):873-7. PubMed ID: 3465267
[TBL] [Abstract][Full Text] [Related]
4. Elevated urokinase-type plasminogen activator level and bleeding in amyloidosis: case report and literature review.
Sane DC; Pizzo SV; Greenberg CS
Am J Hematol; 1989 May; 31(1):53-7. PubMed ID: 2495717
[TBL] [Abstract][Full Text] [Related]
5. Inherited disorders of the fibrinolytic pathway.
Jain S; Acharya SS
Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
[TBL] [Abstract][Full Text] [Related]
6. Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients.
Wassenaar T; Black J; Kahl B; Schwartz B; Longo W; Mosher D; Williams E
Hematol Oncol; 2008 Dec; 26(4):241-6. PubMed ID: 18613223
[TBL] [Abstract][Full Text] [Related]
7. [Congenital deficiency of the fibrinolysis inhibitor alpha 2-antiplasmin as a cause of hemorrhagic diathesis].
Leebeek FW; Knot EA; Kluft C
Ned Tijdschr Geneeskd; 1988 Jan; 132(4):167-70. PubMed ID: 3277073
[No Abstract] [Full Text] [Related]
8. Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.
Williams EC
Arch Intern Med; 1989 Aug; 149(8):1769-72. PubMed ID: 2475079
[TBL] [Abstract][Full Text] [Related]
9. Acquired alpha-2 anti-plasmin deficiency secondary to amyloidosis.
Clyne LP; Caldwell AB
Thromb Haemost; 1987 Aug; 58(2):797. PubMed ID: 3672434
[No Abstract] [Full Text] [Related]
10. Increased fibrinolysis and amyloidosis.
Liebman H; Chinowsky M; Valdin J; Kenoyer G; Feinstein D
Arch Intern Med; 1983 Apr; 143(4):678-82. PubMed ID: 6340622
[TBL] [Abstract][Full Text] [Related]
11. Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma.
Takahashi H; Koike T; Yoshida N; Kitahara O; Hanano M; Shibata A; Aoki N
Am J Hematol; 1986 Oct; 23(2):153-66. PubMed ID: 2944378
[TBL] [Abstract][Full Text] [Related]
12. A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin.
Kluft C; Vellenga E; Brommer EJ; Wijngaards G
Blood; 1982 Jun; 59(6):1169-80. PubMed ID: 6177359
[TBL] [Abstract][Full Text] [Related]
13. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
Carpenter SL; Mathew P
Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
[TBL] [Abstract][Full Text] [Related]
14. A bleeding disorder due to deficiency of alpha 2-antiplasmin.
Miles LA; Plow EF; Donnelly KJ; Hougie C; Griffin JH
Blood; 1982 Jun; 59(6):1246-51. PubMed ID: 7082827
[TBL] [Abstract][Full Text] [Related]
15. Congenital alpha(2)-plasmin inhibitor deficiencies: a review.
Favier R; Aoki N; de Moerloose P
Br J Haematol; 2001 Jul; 114(1):4-10. PubMed ID: 11472338
[No Abstract] [Full Text] [Related]
16. Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses.
Bouma B; Maas C; Hazenberg BP; Lokhorst HM; Gebbink MF
J Thromb Haemost; 2007 Jun; 5(6):1139-42. PubMed ID: 17371485
[No Abstract] [Full Text] [Related]
17. [Congenital deficiency of alpha 2-plasmin inhibitor].
Yoshinaga H; Hirosawa S
Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):488-90. PubMed ID: 9833551
[No Abstract] [Full Text] [Related]
18. Hemostasis associated with abnormalities of fibrinolysis.
Aoki N
Blood Rev; 1989 Mar; 3(1):11-7. PubMed ID: 2650772
[TBL] [Abstract][Full Text] [Related]
19. Alpha 2-plasmin inhibitor and its deficiency states.
Saito H
J Lab Clin Med; 1988 Dec; 112(6):671-8. PubMed ID: 3057093
[No Abstract] [Full Text] [Related]
20. Implications of excessive fibrinolysis and alpha(2)-plasmin inhibitor deficiency in patients with severe head injury.
Kushimoto S; Yamamoto Y; Shibata Y; Sato H; Koido Y
Neurosurgery; 2001 Nov; 49(5):1084-9; discussion 1089-90. PubMed ID: 11846901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
